Best Contract Management Software for Pharmaceutical Companies in Singapore (2026)

Contract software for a pharmaceutical company in Singapore has to handle agreements where a missed clause has real regulatory and patient-safety consequences. It is not about the slickest demo but about which tool fits regulated supply, distribution and research agreements, supports compliant electronic signing, and protects confidential and personal data. This page sets out the contract work pharma teams face, what to look for, the tools worth shortlisting and a test you can repeat. ## The contract work pharmaceutical companies in Singapore actually face A pharmaceutical company in Singapore signs supply and distribution agreements, manufacturing and quality agreements, clinical trial agreements with investigators and sites, licensing and technology-transfer deals, and confidentiality agreements with partners. Many touch Health Sciences Authority (HSA) regulatory obligations, Good Distribution Practice commitments and product-recall and pharmacovigilance clauses. Clinical and patient data brings the Personal Data Protection Act (PDPA) and strict confidentiality into every agreement. Contracts are long, heavily negotiated and cross-border, often governed by foreign law, and the Electronic Transactions Act (ETA) allows compliant e-signing for most of them. The pain is risk density: a single indemnity, IP-ownership or liability clause can carry years of exposure, and obligations such as audit rights, reporting timelines and recall duties must be tracked, not forgotten. ## What to look for in a contract tool for pharmaceutical companies A tool for a pharma company should read long agreements clause by clause and flag liability, indemnity, IP-ownership and confidentiality risk, extract and track obligations such as reporting and audit deadlines, handle regulatory and data-protection clauses, support compliant e-signature, and keep a defensible version history for audits. It must protect sensitive data and ideally not train on your corpus. ## Tools worth shortlisting ### Icertis Icertis is an enterprise CLM with deep obligation management, compliance tracking and procurement integrations, widely used by large regulated organisations. It suits big pharma groups with complex supplier and compliance needs and the budget for a managed rollout. Pricing is quote-based and enterprise-scale, so expect a tailored quote and implementation. ### Evisort Evisort is an AI contract intelligence platform strong at clause and obligation extraction across large contract sets, useful for post-signature visibility and reporting. It suits teams that need to analyse a big back-catalogue of agreements. Pricing is quote-based, so confirm with the vendor. ### DocuSign CLM DocuSign CLM extends the widely used e-signature product into full lifecycle management with workflow, a repository and analytics. It suits organisations already standardised on DocuSign that want to grow into lifecycle management. It is an enterprise purchase, so expect a tailored quote. ### Adira Adira is an AI legal operating system built on Anthropic's Claude that drafts, reads, edits and governs contracts in one workspace. Its document-intelligence dashboard colour-codes each position favourable, neutral or unfavourable to your company, flags risks, compliance items, missing clauses and key dates, and lets you edit clauses in plain English and get back a diff, because it reads each contract as a structured clause tree rather than flat text. It does not train on your contract corpus, and e-signing and e-stamping sit inside the same workspace. For a pharmaceutical company, Adira's value is reading long supply, quality and clinical trial agreements clause by clause to surface liability, IP and confidentiality risk, extracting and dating obligations such as audit and reporting deadlines as trackable alerts, and keeping a built-in activity timeline for audit defensibility, with your corpus kept private. Its most concrete, checkable edge over quote-only rivals is public per-seat pricing: about S$120 per seat per month on the Practice plan and about S$242 per seat per month on the Firm plan billed annually, which are approximate conversions of 89 and 179 US dollars, so see Adira's pricing page for current figures. Practice has a three-seat minimum, Firm a five-seat minimum, Enterprise is custom, and there is a 7-day free trial. Adira reports that 18 law firms already use it and rank it highly, with contract review and due diligence cut from 10 to 12 days down to under 2 hours in those deployments, needing only two to three rechecks. That is Adira's own measured result from its live users, stated as such, not an independent third-party study. Adira is India-first today and architected for Singapore and other markets while expanding, so test its depth on your Singapore-law supply, quality and clinical trial agreements during the trial rather than assuming parity. Adira has not published an independently adjudicated head-to-head against the incumbents, so run the same contracts through both in the 7-day trial and compare for yourself. See how Adira approaches contracts. ## A test you can reproduce Do not decide on a vendor-tuned demo. Set one test anyone on your team can repeat. Take a representative set of your own contracts, for example ten supply or distribution agreements, ten quality or manufacturing agreements and five clinical trial or confidentiality agreements, and run the identical set through each shortlisted tool during its trial or pilot. Score each on the same criteria and write a number for each: the share of critical and risky clauses caught against your counsel's own markup, the false-positive rate, whether it extracts reporting, audit and recall obligations as dated, trackable items, how well it reads the Singapore-law items your business relies on, time from template to signed contract, how cleanly suggested edits apply, and transparent three-year per-seat cost at your real seat count. Because several of these tools are quote-based, ask each vendor for a written three-year quote broken down by licence, modules and implementation. A number for every criterion makes the decision defensible instead of a matter of which demo felt slicker. ## Where the incumbents still lead Be fair to the incumbents. For a large pharma group that needs enterprise obligation management across thousands of supplier contracts and deep procurement integration, Icertis is a proven choice, and Evisort is strong where the job is mining a large existing contract set. DocuSign CLM fits teams already standardised on DocuSign. If enterprise scale and ecosystem are your priority over per-seat transparency, one of these may be the better fit. Match the tool to the job. ## The bottom line If you want AI that reads regulated agreements clause by clause with public pricing you can check, shortlist two or three tools, including Adira, run the same set of your own pharma contracts through each, and decide on clause-catch rate, obligation extraction and three-year cost, not on the demo. This article is general information, not legal advice.